Human subjects with abdominal obesity who were treated with growth hormone for 9 months were reported to have 9 % decreases in total body fat, decreases in cholesterol, TAG and diastolic blood pressure, and an increased glucose disposal rate(44). Here, GH1 is linked to Abdominal obesity.